Valuation (43%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 156.84 | 41.62 |
| PEG Ratio (TTM) | 0.57 | 7.41 |
| P/S Ratio (TTM) | 2.15 | 4.11 |
| P/B Ratio (TTM) | 2.23 | 7.29 |
| P/FCF Ratio (TTM) | -81.83 | 66.10 |
| Price to 5YR AVG Earnings Ratio | -70.36 | 47.08 |
| Price to 5YR AVG FCF Ratio | 34.04 | 89.95 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.66% | 5.09% |
| ROE (TTM) | 1.43% | 19.49% |
| Net Profit Margin (TTM) | 1.37% | 4.79% |
| ROIC 5YR AVG | 3.15% | 9.58% |
Growth (67%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 169.61% | 33.73% | 54.76% |
| Revenue | -0.28% | -8.43% | -4.96% |
| Net Income | 170.69% | 31.50% | 53.05% |
| Cash Flow | -15.41% | 40.21% | 21.64% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.11 | 0.91 |
| Quick Ratio (TTM) | 1.11 | 0.87 |
| D/E Ratio (TTM) | 0.60 | 1.55 |
| Interest Coverage (TTM) | 2.44 | 9.53 |
| Piotroski F-Score | 4 | 7 |
| Altman Z-Score | 2.09 | 2.91 |
| LTL to 5YR AVG FCF | 7.61 | 28.79 |
| Shares Outstanding Growth 5YR AVG | 1.20% | 0.02% |